Michael Gelband’s Precigen PGEN Stock Holding History

Michael Gelband’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.78M	Sell	311,930 -32,415	-9%	-$140K	0.01%	867
2026 Q1	$1.33M	Buy	+344,345	New	+$1.41M	0.01%	910
2022 Q3	–	Sell	-19,525	Closed	-$26K	–	2203
2022 Q2	$26K	Sell	19,525 -843	-4%	-$1.25K	﹤0.01%	1843
2022 Q1	$43K	Sell	20,368 -93,387	-82%	-$227K	﹤0.01%	2072
2021 Q4	$422K	Buy	113,755 +41,547	+58%	+$179K	﹤0.01%	1502
2021 Q3	$360K	Buy	72,208 +15,483	+27%	+$89.1K	﹤0.01%	1545
2021 Q2	$370K	Buy	56,725 +27,751	+96%	+$194K	﹤0.01%	1608
2021 Q1	$200K	Buy	28,974 +11,251	+63%	+$95.1K	﹤0.01%	1875
2020 Q4	$181K	Sell	17,723 -25,450	-59%	-$165K	﹤0.01%	1756
2020 Q3	$151K	Buy	43,173 +30,573	+243%	+$145K	﹤0.01%	1542
2020 Q2	$63K	Buy	+12,600	New	+$42.9K	﹤0.01%	1674

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Michael Gelband's PGEN Position: Q2 2026 in Review

Michael Gelband reduced its Precigen (PGEN) stake by 9.4% in Q2 2026, selling an estimated $140K and leaving 311,930 shares worth $1.78M. The position accounts for 0.01% of the portfolio, ranked #867.

Michael Gelband first reported a position in PGEN in Q2 2020 and has held it in 11 quarters since. 209 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

Michael Gelband held 311,930 shares of Precigen worth $1.78M as of Q2 2026.
Michael Gelband sold 32,415 Precigen shares in Q2 2026, an estimated $140K.
Precigen made up 0.01% of Michael Gelband's portfolio in Q2 2026, its #867 holding.
Michael Gelband first reported a position in Precigen in Q2 2020 and has held it in 11 quarters since.
209 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.